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A chief Ca2+ entry pathway in immune cells is store-
operated Ca2+ (SOC) influx, which is triggered by
depletion of Ca2+ from the endoplasmic reticulum
(ER). However, its physiological role in B cells
remains elusive. Here, we show that ER calcium
sensors STIM1- and STIM2-induced SOC influx is
critical for B cell regulatory function. B cell-specific
deletion of STIM1 and STIM2 in mice caused
a profound defect in B cell receptor (BCR)-induced
SOC influx and proliferation. However, B cell devel-
opment and antibody responses were unaffected.
Remarkably, B cells lacking both STIM proteins
failed to produce the anti-inflammatory cytokine
IL-10 because of defective activation of nuclear
factor of activated T cells (NFAT) after BCR stimula-
tion. This resulted in exacerbation of experimental
autoimmune encephalomyelitis, a mouse model of
multiple sclerosis. Our data establish STIM-depen-
dent SOC influx as a key signal for B cell regulatory
function required to limit autoimmunity.
INTRODUCTION
B cells play an essential role in the regulation of immune
responses. Upon encountering their cognate antigens through
their B cell receptors (BCRs), B cells take onmultiple functions in-
cluding antibody production, antigen-presentation, and effector
T cell differentiation. In addition to protective roles against
pathogenesis, B cells also serveas negative regulators of autoim-
munity by secreting anti-inflammatory cytokines such as inter-
leukin-10 (IL-10) and transforming growth factor-b (TGF-b)
(Lund and Randall, 2010), which have been shown to contribute
to the suppression of experimental autoimmune encephalomy-
elitis (EAE) (Fillatreau et al., 2002; Matsushita et al., 2008), inflam-
matory bowel disease (Mizoguchi et al., 2002), and collagen-
induced arthritis (Evans et al., 2007; Mauri et al., 2003).
A central response to BCR stimulation is intracellular Ca2+
elevation, which leads to activation of many transcription factors
to regulate the gene expression that mediates diverse geneticprograms (Feske, 2007; Macian, 2005). Increasing cytosolic
Ca2+ concentrations can occur via two main mechanisms:
Ca2+ release from endoplasmic reticulum (ER) stores and Ca2+
influx from outside the cell across the plasma membrane. BCR
stimulation activates several protein tyrosine kinases and subse-
quently phospholipase C (PLC)-g2. Activated PLC-g2 generates
the secondmessenger inositol-1,4,5-trisphosphate, which binds
to its receptor in the ERmembrane, leading to the rapid and tran-
sient release of Ca2+ into the cytosol from ER stores. In turn, the
decrease of ER luminal Ca2+ concentration triggers the opening
of Ca2+ channels in the plasma membrane, which can induce
a sustained influx of extracellular Ca2+. These processes are
known as store-operated Ca2+ (SOC) influx, which is an essential
pathway for maintaining sustained Ca2+ signaling in immune
cells (Baba and Kurosaki, 2009; Parekh and Putney, 2005). The
induction of SOC influx critically requires the ER Ca2+ sensor,
stromal interaction molecule 1 (STIM1) (Liou et al., 2005; Roos
et al., 2005), and the SOC channel Orai1 (also called CRACM1)
(Feske, 2007). STIM1 functions as the chief ER-resident protein
to activate SOC influx by detecting ER Ca2+ depletion in many
cells including mast cells (Baba et al., 2008), T cells (Oh-Hora
et al., 2008), platelets (Varga-Szabo et al., 2008), and macro-
phages (Braun et al., 2009). STIM2, a related homolog of
STIM1, also activates SOC influx, but is less effective than
STIM1 in T cells (Oh-Hora et al., 2008). It has an additional
distinct function in regulating basal cytosolic and ER Ca2+
concentrations (Brandman et al., 2007).
The importance of Ca2+ influx is underscored by reports that
patients with mutations in the Orai1 or Stim1 genes presented
with severe combined immunodeficiency and defects in SOC
influx in lymphocytes (Feske et al., 2006; Picard et al., 2009).
Stim1 mutation has also been associated with autoimmune
symptoms. However, abnormal T cell functions in these diseases
make it difficult to understand B cell-intrinsic functions. Although
Ca2+ signaling in B cells is widely assumed to be essential, the
importance of SOC influx for physiological B cell functions was
unclear.
To directly assess the involvement of SOC influx in B cells, we
generated mice with B cell-specific deletions of Stim1 and
Stim2. We found that STIM1 and STIM2 critically regulated
BCR-induced SOC influx and proliferation in vitro, and yet they
were dispensable for B cell development and antibody
responses in vivo. The ablation of STIM1 and STIM2 in B cellsImmunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc. 703
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Figure 1. STIM1 and STIM2 are Required for SOC Influx in B Cells
(A) Ca2+-mobilization profiles, monitored by Indo-1 AM imaging. Ca2+ release was elicited in Mb1cre/+, Stim1f/fMb1cre/+, Stim2f/fMb1cre/+, and Stim1f/fStim2f/f
Mb1cre/+ B cells by stimulation with thapsigargin (TG) or anti-IgM F(ab)’2 (anti-IgM) in Ca
2+-free conditions (0.5 mM EGTA), and Ca2+ influx was induced by
restoration of the extracellular Ca2+ concentration to 2 mM.
(B) Ca2+-mobilization profiles in the presence of 2 mM extracellular Ca2+ in Mb1cre/+, Stim1f/fMb1cre/+, Stim2f/fMb1cre/+, and Stim1f/fStim2f/fMb1cre/+ B cells
after stimulation with anti-IgM. (A and B) B220+ cells were gated and analyzed. All values are plotted as the FL5/FL4 fluorescence ratio (FL4 = 500–520 nm;
FL5 = 400–420 nm). Data are representative of at least three independent experiments.
Immunity
Role of Ca2+ Influx in B Cell Regulatory Functioncaused defects in activation of nuclear factor of activated T cells
(NFAT), B cell IL-10 production, and suppression of an EAE
model of autoimmune disease. These results provide genetic
evidence for the significance of STIM-dependent Ca2+ signaling
in B cell regulatory function.
RESULTS
B Cell-Specific Deletions of STIM1 and STIM2 in Mice
We generated mice with specific deletions of the genes encod-
ing STIM1 and STIM2 in B cells by using the cre recombinase–
loxP system. LoxP-flanked (floxed [f]) Stim1 (Baba et al., 2008)
and Stim2 (Figure S1A available online) were deleted fromB cells
by crossing of Stim1f/f and Stim2f/f mice with mb-1 cre mice
carrying a cre transgene in one of the Mb1 alleles (Mb1cre/+)
(Hobeika et al., 2006). We confirmed that Stim1f/fMb1cre/+,
Stim2f/fMb1cre/+, and Stim1f/fStim2f/fMb1cre/+ mice had re-
combination of these genes in B cells, resulting in the complete
ablation of STIM1 and STIM2 proteins in splenic B cells by immu-
noblot analysis (Figure S1B). Of note, B cell development in
spleen, bone marrow, and peritoneal cavity of Stim1f/fMb1cre/+,
Stim2f/fMb1cre/+, and Stim1f/fStim2f/fMb1cre/+ mice was equiva-
lent to that of Mb1cre/+ mice (Figure S1C). Therefore, STIM1
and STIM2 are dispensable for normal B cell development.
Deficiency of STIM1 and STIM2 in B Cells Impairs
BCR-Mediated SOC Influx
To determine the effects of STIM1 and STIM2 on SOC influx in B
cells, we monitored cytosolic Ca2+ in Stim1f/fMb1cre/+, Stim2f/f
Mb1cre/+, Stim1f/fStim2f/fMb1cre/+, and control Mb1cre/+ B cells
after Ca2+ depletion from ER stores in response to anti-IgM or
thapsigargin (TG), an ER Ca2+ pump inhibitor. Stim1f/fMb1cre/+
B cells showed considerably less Ca2+ influx after treatment
with TG or anti-IgM, whereas Stim2f/fMb1cre/+ B cells had
a mild decrease (Figure 1A). The loss of both STIM1 and
STIM2 led to almost complete suppression of SOC influx
induced by stimulation with TG or anti-IgM (Figure 1A). To further
assess the effect of STIM proteins on Ca2+mobilization, we stim-
ulated B cells with anti-IgM in the presence of extracellular Ca2+.
STIM1- or STIM2-deficient B cells exhibited a modest reduction
in Ca2+ rises, whereas cytosolic Ca2+ concentrations were much704 Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc.lower when both STIM1 and STIM2 were absent (Figure 1B).
These results collectively indicate that both STIM1 and STIM2
positively and cooperatively regulate SOC influx after BCR stim-
ulation and that the effect of STIM2 is smaller than STIM1.
BCR-Mediated Proliferation and Survival Require
SOC Influx
We next examined proliferative responses to mitogenic stimuli.
Purified B cells were labeled with cabroxyfluorescein diacetate
succinimidyl ester (CFSE), and cell division was then monitored
by CFSE dilution. BCR stimulation induced several rounds of
cell division in control B cells, whereas Stim1f/fStim2f/fMb1cre/+
B cells failed to divide in response to anti-IgM stimulation (Fig-
ure 2A). The absence of STIM1, but not STIM2, reduced the
frequency of BCR-evoked proliferation. On the other hand, anti-
CD40 or lipopolysaccharide (LPS)-mediated proliferation was
normal in B cells lacking STIM proteins (Figure 2A). Importantly,
stimulation with anti-CD40 or LPS did not induce Ca2+ influx
even in control B cells (data not shown), indicating that anti-
CD40 and LPS activate B cells in a STIM-independent manner.
We also characterized the proliferative response to costimulation
of anti-IgM with IL-4 or anti-CD40. The defective proliferation in
BCR-stimulated Stim1f/fStim2f/fMb1cre/+ B cells was consider-
ably restored by the addition of anti-CD40, while IL-4 had
a smaller effect (Figure 2B). In accordance with the proliferation
results, B cells lacking both STIM1 and STIM2 did not survive
after BCR stimulation, but normally did in response to anti-
CD40 or LPS (Figure 2C). Again, costimulation with anti-IgM
and anti-CD40 or IL-4 significantly restored the impaired BCR-
induced survival of Stim1f/fStim2f/fMb1cre/+ B cells, although
IL-4 did considerably less for their survival than did anti-CD40
(Figure 2D). These results demonstrate an essential STIM-medi-
ated Ca2+ signaling requirement for B cell proliferation and
survival when induced by stimulation with BCR, but not anti-
CD40 or LPS. Signals evoked by anti-CD40 or IL-4 can compen-
sate for STIM protein deficiencies after BCR stimulation.
Normal Antibody Responses in Mice with B Cells
Lacking STIM1 and STIM2
To assess the consequences of altered in vitro B cell functions
on the immune system, we investigated the abilities of gene
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Figure 2. BCR-Mediated Proliferation and Survival Require SOC Influx
(A and B) Proliferation ofMb1cre/+, Stim1f/fMb1cre/+, Stim2f/fMb1cre/+, and Stim1f/fStim2f/fMb1cre/+ B cells labeled with CFSE and stimulated for 72 hr with anti-IgM
(1 or 10 mg/ml), anti-CD40 (10 mg/ml) or LPS (10 mg/ml) (A) or with a combination of anti-IgM (10 mg/ml) and either IL-4 (40 ng/ml) or anti-CD40 (10 mg/ml) (B).
Percentages of proliferating B cells were assessed by CFSE dilution.
(C and D) Survival of Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells cultured as described in (A) (for C) and (B) (for D), stained with TO-PRO-3, and presented as
a percentage of viable TO-PRO-3- cells.
(A–D) Results represent one of three similar experiments. Data are presented as mean ± SEM. *p < 0.05, **p < 0.001 versus Mb1cre/+ B cells.
Immunity
Role of Ca2+ Influx in B Cell Regulatory Functiontargeted mice to produce antibodies in vivo. Serum titers of IgM,
IgG1, IgG2b, IgG3, and IgA were comparable among unimmu-
nizedStim1f/fMb1cre/+,Stim2f/fMb1cre/+,Stim1f/fStim2f/fMb1cre/+,
and control Mb1cre/+ mice (Figure S2A). To evaluate T cell-inde-
pendent (TI) antibody responses, we elicited immunization of
mice of all four genotypes with the 4-hydroxy-3-nitrophenyl
(NP)-LPS or NP-Ficoll. The mutant mice showed normal
antigen-specific IgM and IgG3 responses to both TI antigens
(Figures 3A and 3B and Figure S2B). We also examined T cell-
dependent (TD) antibody responses by immunization with NP-
chicken g globulin (CGG) and monitored the production of
antigen-specific IgM and IgG1 antibodies. Mutant mice showed
comparable primary immune responses to those of control mice
(Figure 3C and Figure S2C). After rechallenge with NP-CGG,
antigen-specific antibody production was also within the normal
range, indicating that the ability to mount primary and memory
responses is not affected by the complete absence of STIM
proteins. During TD responses, proliferating B cells in lymphoidorgans form germinal centers essential for the normal generation
of memory B cells and plasma cells that produce high-affinity
antibodies (Klein and Dalla-Favera, 2008). As expected,Mb1cre/+
and Stim1f/fStim2f/fMb1cre/+ mice had similar percentages of
germinal center B cells (defined asB220+FashiGL7+; Figure S2D),
and the affinity maturation of the antibody responses was normal
(Figure S2E). In vitro plasma cell formation of Stim1f/fStim2f/f
Mb1cre/+ B cells in response to LPS or IL-4 plus anti-CD40 was
also intact (Figure S2F). Thus, we conclude that STIM-mediated
Ca2+ influx is not essential either for TI or TD antibody responses.
STIM-Dependent Ca2+ Influx Is Required
for B Cell IL-10 Production
Published studies have shown that in addition to protection
against pathogens, B cells negatively regulate hyperinflamma-
tion during autoimmune diseases by production of anti-
inflammatory cytokines such as IL-10 and TGF-b (Mauri and
Ehrenstein, 2008). To determine whether B cell regulatoryImmunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc. 705
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Figure 3. STIM1 and STIM2 are Dispensable
for Antigen-Specific Antibody Production
(A and B) IgM and IgG3 NP-specific antibody
responses ofMb1cre/+ and Stim1f/fStim2f/fMb1cre/+
mice immunized with NP-LPS (A) or NP-Ficoll (B),
as assessed by NP-specific ELISA.
(C) IgM and IgG1 NP-specific antibody responses
of Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice
immunized with NP-CGG in alum and re-
challenged with NP-CGG 5 weeks after primary
immunization, as assessed by NP-specific ELISA.
Arrowheads indicate the day of secondary immu-
nization. Data are presented as mean ± SD of five
(A and B) or ten (C) mice for each genotype at each
time point.
Immunity
Role of Ca2+ Influx in B Cell Regulatory Functionfunction was affected by loss of STIM1 and STIM2, we first
measured synthesis of mRNA encoding IL-10 and TGF-b in
splenic B cells after mitogenic stimulation with phorbol myristate
acetate (PMA) and ionomycin.We found that transcripts of IL-10,
but not TGF-b, were considerably impaired in the absence of
STIM proteins (Figure 4A and data not shown). In addition, intra-
cellular cytokine staining and ELISA assay showed that Stim1f/f
Stim2f/fMb1cre/+ B cells had compromised IL-10 production
compared with control or single-deficient B cells (Figures 4B
and 4C).
We further evaluated the requirement of STIM proteins for
BCR-induced IL-10 secretion. BCR ligation alone did not induce
IL-10 secretion by naive Mb1cre/+ B cells (Figure 4D) given that
this requires signals from CD40 and/or Toll-like receptors
(TLRs) (Lampropoulou et al., 2008; Yanaba et al., 2009). Given
that BCR stimulation is assumed to potentiate IL-10 secretion
when B cells are first preactivated with anti-CD40 or TLRs
agonists (Lampropoulou et al., 2010), this point was investigated
with B cells by a two-step stimulation that first applied anti-
CD40, and CpG (a TLR9 agonist) or LPS (a TLR4 agonist), and
then anti-IgM. Small amounts of IL-10 were secreted equiva-
lently by Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells after
stimulation with CpG or LPS, but not anti-CD40 (Figure 4D).
The following stimulation of LPS-activated Mb1cre/+ B cells706 Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc.with anti-IgM markedly augmented IL-10
production compared to LPS alone,
whereas CpG preactivation resulted in
no increase of IL-10 secretion (Figure 4D).
Although preactivation ofMb1cre/+ B cells
with anti-CD40 enhanced BCR-induced
IL-10 production, the effect was much
less than with LPS. These results indicate
that BCR signaling reinforced IL-10
production efficiently in LPS-activated B
cells. In striking contrast, Stim1f/fStim2f/f
Mb1cre/+ B cells secreted much less
IL-10 after restimulation with anti-IgM
(Figure 4D). Stim1f/fMb1cre/+ or Stim2f/f
Mb1cre/+ B cells exhibited a modest
reduction of IL-10 secretion, although
less pronounced than Stim1f/fStim2f/f
Mb1cre/+ B cells (Figure S3). Quantitative
reverse transcriptase-polymerase chainreaction (RT-PCR) analysis confirmed that synthesis of IL-10
mRNA was also considerably inhibited in the absence of STIM
proteins (Figure 4E).
To address the capacity of the putative regulatory B cell
subset with a CD1dhiCD5+ phenotype (Yanaba et al., 2008) to
produce IL-10 in the absence of STIM proteins, we measured
the secretion of IL-10 by purified CD1dhiCD5+ B cells from
Mb1cre/+ or Stim1f/fStim2f/fMb1cre/+ mice after stimulation with
LPS and anti-IgM. CD1dhiCD5+ B cells, but not CD1dlowCD5
B cells, from Mb1cre/+ mice showed marked IL-10 secretion
whereas CD1dhiCD5+ B cells from Stim1f/fStim2f/fMb1cre/+
mice secreted much less IL-10 (Figure 4F). It is noteworthy that
the absolute numbers of CD1dhiCD5+ B cells was not affected
by loss of STIM proteins (Figure 4G), suggesting that impaired
IL-10 secretion in Stim1f/fStim2f/fMb1cre/+ B cells was not due
to the aberrant development of these regulatory B cells. Thus,
we conclude that BCR-induced IL-10 production is dependent
on STIM proteins.
STIM-Dependent IL-10 Production Requires
Calcineurin-NFAT Activation
The results described above suggested that the impaired Ca2+
influx in Stim1f/fStim2f/fMb1cre/+ B cells leads to defects in the
intracellular signaling events required for IL-10 production. In
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Figure 4. Loss of STIM1 and STIM2 Impairs IL-10 Production by B Cells
(A) Quantitative RT-PCR of mRNA encoding IL-10 in splenic B cells from Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice after stimulation with PMA (100 ng/ml) and
ionomycin (1 mM) for 4 hr, normalized to the expression of GAPDH.
(B) Production of IL-10 by splenic B cells from Mb1cre/+, Stim1f/fMb1cre/+, Stim2f/fMb1cre/+, and Stim1f/fStim2f/fMb1cre/+ mice after stimulation with PMA and
ionomycin for 5 hr in the presence of monensin, as assessed by intracellular cytokine staining. Numbers above the outlined area indicate the percentage of cells in
the gate. Data are representative of three independent experiments. On the right, the frequency of IL-10+ B cells is shown. Data shown are pooled from three
independent experiments.
(C) ELISA of IL-10 by splenic B cells after stimulation with PMA and ionomycin for 24 hr.
(D) ELISA of IL-10 by Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells (naive B cells) and their B cells cultured with anti-CD40, CpG, or LPS for 48 hr (anti-CD40-,
CpG-, and LPS-activated B cells) followed by stimulation with anti-IgM for 24 hr. < DL, below detection limit.
(E) Quantitative RT-PCR of mRNA encoding IL-10 in LPS-activated Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells after stimulation with anti-IgM for 1 hr or 3 hr,
normalized to the expression of GAPDH.
(F) ELISA of IL-10 by CD1dhiCD5+B220+ and CD1dloCD5B220+ B cells isolated fromMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice and cultured with LPS for 48 hr
followed by stimulation with anti-IgM for 24 hr.
(G) Absolute number of CD1dhiCD5+B220+ B cells in spleen from Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice. NS, no significance.
(A, D, E, and F) Data are representative of at least three independent experiments.
(C and G) Data shown are pooled from three independent experiments.
All data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Immunity
Role of Ca2+ Influx in B Cell Regulatory Functiona variety of cells, IL-10 expression is regulated by mitogen-acti-
vated protein kinases (MAPKs) and various Ca2+-activated tran-
scription factors such as CREB, NF-kB, and NFAT (Saraiva and
O’Garra, 2010). Thus, we examined the effects of the deficiency
in STIM proteins on the activation of these molecules. To directly
compare the intracellular signaling events and IL-10 secretion,we first activated Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells
with LPS and then stimulated them with anti-IgM for various
time periods. The activation status of CREB, MAPKs (Jnk, p38,
Erk), NF-kB, and NFAT were assessed by immunoblotting.
Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells had similar phos-
phorylation of CREB, Jnk, p38, Erk, and the NF-kB inhibitorImmunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc. 707
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Figure 5. STIM-Mediated IL-10 Production Requires NFAT Activation
(A) Immunoblot analysis of whole-cell lysates of Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells cultured with LPS for 48 hr (LPS-activated B cells) followed by
stimulation with anti-IgM. p-, phosphorylated; b-actin, loading control.
(B) Confocal microscopy of NFAT nuclear translocation in Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells retrovirally transduced with GFP-NFAT4 (green) and
stimulatedwith anti-IgM for 30min followed byDAPI staining of the nucleus (blue). A proportion of cells with NFAT nuclear translocation is shown on the right. Data
shown are pooled from three independent experiments. *p < 0.001 versus Mb1cre/+ B cells.
(C) ELISA of IL-10 by LPS-activatedMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells treated with dimethyl sulfoxide (DMSO), cyclosporine A (CsA; 1 mM), and FK506
(1.25 mM) for 1 hr followed by stimulation with anti-IgM for 24 hr. *p < 0.001 versus Mb1cre/+ B cells treated with DMSO.
(D) ELISA of IL-10 by LPS-activatedMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells retrovirally transducedwith GFP alone or constitutively active calcineurin (caCN)
followed by stimulation with anti-IgM for 24 hr.
(E) ELISA of IL-10 production by LPS-activatedMb1cre/+ B cells retrovirally transduced with GFP alone or microRNA for NFAT1 (miRNA) followed by stimulation
with anti-IgM for 24 hr. Immunoblot analysis of NFAT1 in whole-cell lysates is shown on the right.
(A, C, D and E) Results represent one of three similar experiments. Data are presented as mean ± SEM. *p < 0.001 versus GFP+ B cells (D and E).
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Role of Ca2+ Influx in B Cell Regulatory FunctionIkBa (Figure 5A), indicating that these signaling events are not
globally affected by STIM proteins. In contrast, BCR-induced
dephosphorylation of NFAT was markedly impaired in Stim1f/f
Stim2f/fMb1cre/+ B cells, although transiently observed at 2 min
after BCR stimulation (Figure 5A). The loss of STIM1 alone, but
not STIM2, also reduced NFAT1 activation (Figure S4A). Very
similar results were obtained with naive B cells stimulated with
anti-IgM alone (Figure S4B), suggesting the significance of
BCR signals themselves. Furthermore, microscopic analysis
revealed a drastic defect in the nuclear translocation of green
fluorescent protein (GFP)-NFAT4 expressed in Stim1f/fStim2f/f
Mb1cre/+ B cells after BCR stimulation (Figure 5B). These results
suggest the importance of STIM-mediated Ca2+ influx for NFAT
activation induced by BCR stimulation.
A key question is whether NFAT is vital for BCR-induced IL-10
production. NFAT is activated by Ca2+ and calmodulin-depen-
dent phosphatase calcineurin. The calcineurin inhibitors cyclo-
sporine A (CsA) and FK506, which inhibited the activation of
NFAT (Figures S4C and S4D), completely suppressed IL-10
secretion (Figure 5C). Reciprocally, expression of a constitutively
active form of calcineurin A (caCN) substantially increased BCR-
induced IL-10 production in both Mb1cre/+ and Stim1f/fStim2f/f
Mb1cre/+ B cells (Figure 5D). Furthermore, silencing of NFAT1
in Mb1cre/+ B cells greatly lowered IL-10 production after BCR
stimulation (Figure 5E). These data collectively provide evidence708 Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc.that STIM-dependent NFAT activation promotes IL-10 produc-
tion during BCR signaling.
Severe EAE Development in Stim1f/fStim2f/fMb1cre/+
Mice
IL-10-producing B cells have a protective role in the T cell-medi-
ated autoimmune disease EAE (Fillatreau et al., 2002). To deter-
mine whether STIM-mediated IL-10 production contributes to B
cell regulatory function in vivo, we elicited EAE in Mb1cre/+ and
Stim1f/fStim2f/fMb1cre/+ mice. After immunization with myelin
oligodendrocyte glycoprotein peptide (MOG35-55), Stim1
f/f
Stim2f/fMb1cre/+ mice exhibited intense exacerbation of devel-
opment and progression of EAE (Figure 6A and Table 1). The
times of disease onset were equivalent, but incidences and
mean maximum scores were significantly higher in Stim1f/f
Stim2f/fMb1cre/+ mice (Table 1). Histopathological analyses
revealed enhanced inflammatory cell infiltration and demyelin-
ation in the spinal cords of Stim1f/fStim2f/fMb1cre/+ mice (Fig-
ure 6B). We also observed increased numbers of CD8+ and
CD4+ T cells, but not B220+ B cells and Gr-1+ neutrophils, in
the spinal cords of Stim1f/fStim2f/fMb1cre/+ mice (Figure 6C). In
addition to effecter T cells such as CD4+ T cells producing
IFN-g (Th1 cells) and IL-17 (Th17 cells), the infiltration of
Foxp3+ regulatory T (Treg) cells and IL-10-producing CD4+
T cells was augmented (Figure 6C), which might represent
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Figure 6. Double Deficiency in STIM1 and STIM2 in B Cells Exacerbates the Severity of EAE In Vivo
(A) Clinical EAE scores for Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice immunized with MOG35-55. The EAE score is shown as mean ± SEM for 12 mice.
(B) Histological analysis of spinal cords harvested fromMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice 28 days after MOG35-55 immunization. Sections were stained
with hematoxylin and eosin (H&E) and Luxol Fast Blue (LFB). Arrowheads indicate inflammatory foci and demyelinated area. Insets (bottom-left corners) show
inflammatory foci and demyelinated area in boxes in main images. Original magnification, x 60 (main images) or3 100 (insets); scale bars represent 100 mm. The
number of inflammatory foci and the demyelinated area is shown on the right.
(C) Absolute number of cells from spinal cords harvested from Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice 28 days after MOG35-55 immunization.
(D) ELISA of IFN-g, IL-17 and IL-10 by splenocytes isolated fromMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice 28 days after EAE induction followed by stimulation
with MOG35-55 for 48 hr. *p < 0.05 versus Mb1
cre/+ mice (A-D).
(E) Absolute number of CD1dhiCD5+B220+ B cells in spleen harvested fromMb1cre/+ andStim1f/fStim2f/fMb1cre/+ mice 28 days after MOG35-55 immunization. Data
are presented as mean ± SEM for five mice.
(F) ELISA of IgG anti-MOG in sera collected fromMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice 18 and 28 days after MOG35-55 immunization. Each circle represents
an individual mouse. Horizontal bars indicate mean values. NS, no significance (E and F).
(A–F) Data shown are pooled from at least three independent experiments.
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Role of Ca2+ Influx in B Cell Regulatory Functiona process to compensate for hyperinflammation in Stim1f/f
Stim2f/fMb1cre/+ mice. It was also noted that the deletion of
STIM proteins in B cells did not affect the suppressive capacity
of splenic Treg cells (Figure S5A) and IL-10 expression of CNS-
infiltrating CD4+ T cells, Gr-1+ neutrophils and F4/80+ macro-
phages, in EAE-induced mice (Figure S5B). EAE is caused by
autoantigen-specific Th1 and Th17 cells that produce IFN-g
and IL-17, respectively (Kuchroo et al., 1993; Park et al., 2005),
whereas the resolution of EAE is associated with increasedproduction of IL-10 (Bettelli et al., 1998). Upon in vitro stimulation
with MOG35-55, splenocytes from Stim1
f/fStim2f/fMb1cre/+ mice
28 days after EAE induction produced more IFN-g and IL-17,
but less IL-10 compared with control cells (Figure 6D). Of note,
numbers of CD1dhiCD5+ B cells in spleen, which could produce
IL-10 to suppress EAE (Matsushita et al., 2008), were not
different between Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice
after MOG35-55 immunization (Figure 6E). Although it has been
suggested that MOG35-55-specific antibodies enhance EAEImmunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc. 709
Table 1. EAE Clinical Scores
Group Incidence
Mean Day
of Onset
(mean ± SEM)
Mean Maximum
Score
(mean ± SEM)
Mb1cre/+ 8/10 (80%) 12.4 ± 0.5 2.8 ± 0.6
Stim1f/fStim2f/fMb1cre/+ 11/11 (100%) 12.8 ± 0.5 4.5 ± 0.3*
Assessment of clinical EAE includes the number of mice that developed
disease, the day of disease onset, and the maximum clinical score of
each mouse obtained over the entire observation period. Data shown
are pooled from two independent experiments; *p < 0.05 versusMb1cre/+
mice.
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Role of Ca2+ Influx in B Cell Regulatory Functionseverity (Linington et al., 1988; Lyons et al., 1999), serum titers of
anti-MOG IgG 18 and 28 days after EAE induction were not
significantly influenced by loss of STIM proteins (Figure 6F).
Collectively, these results indicate that STIM proteins in B cells
are essential to limit the development and progression of EAE.
Moreover, this phenomenon was not associated with differenti-
ation of regulatory B cells or antibody responses against
autoantigens.
STIM-Dependent IL-10 Production by B Cells
Suppresses EAE Development
To determine whether dysregulation of EAE in Stim1f/fStim2f/f
Mb1cre/+ mice arises from the defective production of antigen-
specific IL-10 by B cells, we isolated splenic B cells from mice
28 days after EAE induction (MOG-primed B cells) andmeasured
their IL-10 secretion in recall response to MOG35-55. Stimulation
of control B cells with anti-CD40 alone induced modest IL-10
production, but Stim1f/fStim2f/fMb1cre/+ B cells secreted less
IL-10 (Figure 7A). Concomitant treatment with anti-CD40 and
MOG35-55, but not an irrelevant antigen, proteolipid protein
peptide (PLP178-191), largely augmented IL-10 production by
control B cells, whereas Stim1f/fStim2f/fMb1cre/+ B cells failed to
respond to any antigens (Figure 7A). The impaired IL-10 produc-
tion inmutant B cells was also confirmed by intracellular cytokine
staining (Figure 7B). Thus, STIMproteins are required for antigen-
specific IL-10 secretion by B cells from EAE-induced mice.
We next examined whether STIM proteins in B cells were
responsible for the suppression of EAE severity in vivo. MOG-
primed B cells taken from Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+
mice were adoptively transferred to Stim1f/fStim2f/fMb1cre/+
mice before EAE induction. The mice that received MOG-primed
Mb1cre/+ B cells, but not Stim1f/fStim2f/fMb1cre/+ B cells,
resolved EAE symptoms (Figure 7C). Furthermore, to evaluate
whether the defective IL-10 production by Stim1f/fStim2f/f
Mb1cre/+ B cells leads to the exacerbation of EAE, we retrovirally
expressed IL-10-internal ribosome entry site (IRES)-GFP
constructs in Stim1f/fStim2f/fMb1cre/+ B cells and adoptively
transferred them to B cell-deficient mMTmice, which themselves
develop severe EAE as a result of their lacking B cells (Wolf et al.,
1996). Adaptive transfer of Stim1f/fStim2f/fMb1cre/+ B cells trans-
duced with IL-10-IRES-GFP, but not those transduced with GFP
alone, ameliorated EAE clinical signs of mMT mice (Figure 7D).
Therefore, we conclude that STIM1 and STIM2 are essential
for B cell regulatory function through IL-10 production, which
controls the development of EAE disease.710 Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc.DISCUSSION
In this study, we identified a physiological function for SOC influx
in B cells by analyzing mice with B cell-specific deletions of
STIM1 and STIM2. Our findings indicate that STIM1 and STIM2
are critical for BCR-induced SOC influx, proliferation, NFAT acti-
vation, and subsequent IL-10 production in vitro. Although STIM
proteins are not essential for B cell development and antibody
responses, these molecules suppressed EAE via an IL-10-
dependent mechanism.
B cells from Stim1f/fMb1cre/+ mice had severely impaired SOC
influx, in accordance with our previous study investigating
chicken STIM1-deficient DT40 B cells (Baba et al., 2006). More-
over, the loss of STIM2 in B cells had less effect on SOC influx,
similar to a previous report investigating STIM2-deficient
T cells (Oh-Hora et al., 2008). Importantly, B cells lacking both
STIM1 and STIM2 showed far more suppressed SOC influx
than B cells lacking STIM1 alone. Previous reports have shown
that STIM2 is more sensitive for the reduction in the ER luminal
Ca2+ than STIM1 and elicits persistent SOC influx along with
a small amplitude of Ca2+ mobilization (Brandman et al., 2007),
which suggests that influences of STIM1 and STIM2 on Ca2+
influx have different kinetics and duration. Although further
investigation is needed to discern the precise functional differ-
ences between the two in B cells, our findings clearly point out
the positive and cooperative function of STIM1 and STIM2 for
efficient Ca2+ influx activation in B cells.
The defects in BCR-induced B cell proliferation and survival in
the absence of STIM proteins indicate the importance of SOC
influx, and CD40 signaling, which is STIM-independent, restores
the impaired BCR signals. Because BCR and CD40 signals
induce B cell proliferation and survival through several common
molecules including Cyclin D2 and the antiapoptotic protein
Bcl-xL (Grillot et al., 1996; Lam et al., 2000), the compensational
effect of CD40 may result from their activation. Alternatively,
given the synergistic effect between signals through CD40 and
BCR (Bishop, 2004), their simultaneous stimulation may allow
activation of a Ca2+-independent pathway not used by either
receptor alone.
During TD immune responses, B cells undergo clonal expan-
sion by receiving cognate T cell help through cytokine stimula-
tion and CD40 engagement in germinal centers, leading to
formation of high-affinity plasma cells and memory cells. In our
study, in vitro B cell proliferation induced by BCR stimulation
was entirely dependent on STIM proteins, whereas in vivo
antibody responses to TD antigens seemed to be STIM indepen-
dent. These findings raise at least two possibilities. First, require-
ments for Ca2+ signaling may be different between in vitro and
in vivo responses. Transient Ca2+ release from the ER may be
sufficient for activating molecules responsible for in vivo clonal
expansion. Second, the signals delivered by cytokines or CD40
ligation through the interaction of B cells with T cells in germinal
centers may be sufficient to counteract defects in STIM-depen-
dent responses. This is supported by our data that in vitro
costimulation of anti-IgM with anti-CD40 or IL-4, albeit to a
lesser degree, can greatly restore impaired BCR-induced prolif-
erative and survival responses of Stim1f/fStim2f/fMb1cre/+ B cells.
In addition to TD responses, TI antibody production was not
affected by loss of STIM proteins. Because TI responses are
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Figure 7. STIM-Dependent IL-10 Production by B Cells Suppresses EAE Development
(A) ELISA of IL-10 by splenic B cells isolated fromMb1cre/+ and Stim1f/fStim2f/fMb1cre/+ mice 28 days after EAE induction followed by stimulation with MOG35-55,
PLP178-191 and/or anti-CD40 for 5 days. Data are presented as mean ± SEM. *p < 0.05, **p < 0.001.
(B) Production of IL-10 by splenic B cells isolated fromMb1cre/+ andStim1f/fStim2f/fMb1cre/+ mice 28 days after EAE induction, stimulated withMOG35-55 and anti-
CD40 for 72 hr and then restimulated with PMA and ionomycin for 5 hr in the presence of monensin, as assessed by intracellular cytokine staining. Results
represent one of three similar experiments.
(C) Clinical EAE scores for Stim1f/fStim2f/fMb1cre/+ mice immunized with MOG35-55 after injecting splenic B cells harvested from Mb1
cre/+ and Stim1f/fStim2f/f
Mb1cre/+ mice 28 days after EAE induction (primed Mb1cre/+ and Stim1f/fStim2f/fMb1cre/+ B cells). The EAE score is shown as mean ± SEM for six to ten mice.
*p < 0.05 versus primed Stim1f/fStim2f/fMb1cre/+ B cells.
(D) Clinical EAE scores for mMT mice immunized with MOG35-55 after injecting Stim1
f/fStim2f/fMb1cre/+ B cells retrovirally transduced with GFP alone (mock
Stim1f/fStim2f/fMb1cre/+ B cells) or IL-10-IRES-GFP (IL-10+ Stim1f/fStim2f/fMb1cre/+ B cells). The EAE scores are shown as mean ± SEM for four to six mice.
*p < 0.05 versus Mock Stim1f/fStim2f/fMb1cre/+ B cells.
(A, C, and D) Data shown are pooled from two independent experiments.
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Role of Ca2+ Influx in B Cell Regulatory Functionconsidered to be BCR-mediated immune responses, our data
indicate that in vitro BCR-mediated B cell proliferation does
not directly correspond to TI responses in vivo. Given that
in vivo immune responses are complicated and influenced by
diverse cytokines, complement receptor signals, and interac-
tions with other cells, our results indicate that multiple signals
during immunization permit in vivo antibody responses indepen-
dent of STIM1 and STIM2.
It is known that B cells can secrete IL-10, which is essential for
suppression of EAE autoimmune disease (Fillatreau et al., 2002).
EAE is induced by immunization of mice with MOG35-55 together
with Mycobacterium tuberculosis that serves as an agonist for
TLR2 and TLR4. Ablation of TLR2, TLR4, or TLR signalingadaptor molecule MyD88 in B cells impair IL-10 production
and thereby exacerbated EAE development (Lampropoulou
et al., 2008). However, TLR stimulation is not enough, given
that activation via BCR and CD40 is also necessary for B cells
to suppress autoimmunity. This follows from the fact that bone
marrow chimeric mice with B cells bearing a fixed surface IgM
antigen receptor or lacking CD40 show no recovery from EAE
(Fillatreau et al., 2002). Nevertheless, in vitro, TLR stimulation,
but not anti-IgM stimulation alone, allows B cells to secrete
IL-10. These data suggest that stepwise stimulation or its combi-
nation will determine the ability to produce IL-10. Indeed, our
results showing that B cells first activated with LPS robustly
promote IL-10 secretion after restimulation with BCR supportImmunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc. 711
Immunity
Role of Ca2+ Influx in B Cell Regulatory Functionthe idea of a stepwise stimulation mechanism for IL-10 produc-
tion. Furthermore, our finding that such BCR-dependent IL-10
production is diminished in B cells lacking STIMproteins strongly
suggests that SOC influx induced by BCR stimulation drives
IL-10 expression.
Although the mechanism for IL-10 production by B cells is
unclear, we here have identified NFAT as a crucial transcription
factor responsible for IL-10 production during BCR ligation.
This implies that the failure of STIM-deficient B cells to produce
IL-10 upon BCR stimulation may have resulted from a lack of
continuous NFAT activation. This interpretation is supported by
many studies showing that optimal cytokine production by
T cells requires sustained Ca2+ influx and prolonged nuclear
localization of NFAT (Feske, 2007). IL-10 expression is controlled
by variousmolecular mechanisms under different stimuli in many
types of cells (Saraiva and O’Garra, 2010). In agreement with our
study, others have shown that the calcineruin-NFAT pathway is
involved in IL-10 production probably by Ca2+-related stimuli in
neutrophils, dendritic cells, and Th2 and Th17 cells (Ghosh
et al., 2010; Goodridge et al., 2007; Greenblatt et al., 2010).
Thus, the calcineurin-NFAT pathway may represent a common
mechanism for Ca2+-drived IL-10 expression through STIM
proteins. It should be noted that BCR stimulation alone can acti-
vate NFAT, but not the induction of IL-10 secretion in naive B
cells. Although our results do not directly address the issue of
why preactivation with LPS is necessary for BCR-evoked IL-10
production, we have three speculations. First, TLR signaling
may cause B cell differentiation, thereby allowing them to
produce BCR-dependent IL-10. It has been reported that IL-10
is produced exclusively by CD138+CD19+ plasmablast and/or
plasma cells during Salmonella infection (Neves et al., 2010).
When cultured with LPS in vitro, naive B cells differentiate into
plasma cells via plasmablasts, which suggests that some LPS-
activated B cells may become plasmablasts that predominantly
secrete BCR-dependent IL-10. Second, TLR-signaling may be
required for activation of transcription factors that collaborate
with NFAT for IL-10 expression. Indeed, NFAT proteins interact
with many transcription factors including AP-1, IRF4, GATA3,
C/EBP, cMAF, and Mef2 to produce various cytokines in
T cells (Macian, 2005), which suggests that additional compo-
nents downstream of TLR signals serve as NFAT transcriptional
partners to express IL-10 in B cells. Finally, TLR signals may
cause changes in the chromatin structure at the Il10 locus for
efficient IL-10 production induced by following BCR signals.
Several studies have suggested the importance of chromatin
remodeling as initial events leading to IL-10 transcription
(Saraiva and O’Garra, 2010). Thus, the mechanism of IL-10
expression merits further investigation.
Our in vitro observations of impaired IL-10 production by B
cells in the absence of STIM proteins are consistent with the
defective suppression of autoimmune disease in Stim1f/fStim2f/f
Mb1cre/+ mice. The functional importance of STIM proteins in
B cells was shown by the impaired amelioration of EAE develop-
ment due to a failure of antigen-specific IL-10 production by
B cells. That MOG-primed B cells from Stim1f/fStim2f/fMb1cre/+
mice secreted less IL-10 in response to in vitro recall MOG and
anti-CD40 stimulation compared to control mice emphasizes
the importance of SOC influx for IL-10 secretion by autoanti-
gen-specific B cells. In contrast, CD40 ligation alone showed712 Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc.less IL-10 secretion in MOG-primed Stim1f/fStim2f/fMb1cre/+ B
cells, which may explain the significance of in vivo BCR stimula-
tion for generating IL-10-producing B cells given that in vitro
CD40-mediated signals are independent of STIM proteins.
Although the nature of splenic regulatory B cells remains unclear,
previous studies have shown that adoptive transfer of a splenic
CD1dhiCD5+ B cell subset selectively normalizes EAE in B cell-
depleted mice (Matsushita et al., 2008) or CD19-deficient mice
(Matsushita et al., 2010), which suggests that it is a central
subset of regulatory B cells in EAE. In our study, the numbers
of splenic CD1dhiCD5+ B cell subset were not affected during
EAE development by loss of STIM proteins, which suggests
that the inability to suppress EAE in Stim1f/fStim2f/fMb1cre/+
mice may be caused by a functional defect in IL-10 production
by regulatory B cells, but not its developmental defect. However,
the adaptive transfer of CD1dhiCD5+ B cells from naiveMb1cre/+
mice into Stim1f/fStim2f/fMb1cre/+ mice 24 hr before EAE induc-
tion did not reduce disease severity (data not shown). It may
be possible that CD1dhiCD5+ B cells may not be the main or
the only regulatory B cell subset in this model. Another likely
explanation is that Stim1f/fStim2f/fMb1cre/+ recipient mice have
normal number of CD1dhiCD5+ B cells, which might compete
with adoptively transferred CD1dhiCD5+ B cells for antigen
response and/or colonization to suppress T cell-mediated
inflammation. In line with this possibility, CD19-deficient mice
or mice injected with anti-CD20 mAb used in previous studies
lack endogenous CD1dhiCD5+ B cells. In addition, when wild-
type recipient mice are given CD1dhiCD5+ B cells from naive
mice 24 hr before EAE induction, the reduction of EAE severity
is not detectable (Matsushita et al., 2010). Therefore, further
studies are needed to elucidate the importance of STIM proteins
for in vivo suppressive capacity of CD1dhiCD5+ B cells, and the
involvement of unidentified autoantigen-reactive B cells that
potentiate or produce IL-10 remains possible. In summary, our
results define a physiological function of SOC influx in B cells
and formally demonstrate that STIM1 and STIM2 are critical
mediators of B cell regulatory function. They limit autoimmune
disease by supporting IL-10 production.EXPERIMENTAL PROCEDURES
Mice and Immunization
Mice with the loxP-flanked Stim1 allele have been described previously (Baba
et al., 2008). The generation of Stim2f/f mice is described in detail in the
Supplemental Experimental Procedures. The mb-1 cre (Hobeika et al., 2006)
and mMT mice (Kitamura et al., 1991) have been described previously.
We generated Stim1f/fMb1cre/+, Stim2f/fMb1cre/+, and Stim1f/fStim2f/fMb1cre/+
mice by crossing of Stim1f/f and/or Stim2f/f mice with mb-1 cre mice. Mice
were given intraperitoneally (i.p.) with 100 mg of NP-CGG in alum, 50 mg NP-
Ficoll, or 50 mg NP-LPS (Biosearch Technologies). For secondary immuniza-
tion, mice were given i.p. with 50 mg NP-CGG without adjuvant. Mice were
maintained under specific pathogen-free conditions, and all protocols were
approved by the RIKEN Animal Committee.Ca2+ Measurement
Cytosolic Ca2+ concentrations were measured as described previously (Baba
et al., 2006). Splenocytes were loadedwith indo-1 acetoxylmethylester (Indo-1
AM) and Pluronic F-127 (Invitrogen) and stained with antibody to B220. Cells
were stimulated with 10 mg/ml anti-mouse IgM F(ab)’2 (Jackson Immunore-
search) or 2 mM thapsigargin (Calbiochem). Changes in fluorescence intensity
were monitored on a LSR flow cytometer (BD Biosciences).
Immunity
Role of Ca2+ Influx in B Cell Regulatory FunctionEAE Induction
EAE was induced by subcutaneous immunization with 200 mg of MOG35-55
(Toray Research Center) emulsified in complete Freund’s adjuvant (CFA)
containing 500 mg of heat-killed mycobacterium tuberculosis H37RA (Sigma-
Aldrich). Mice also received 200 ng of pertussis toxin (List Biological laborato-
ries) i.p. in 0.2 ml of PBS on the same day and 2 days later. Clinical signs of EAE
were assessed daily with a 0-6 scoring system (0, no signs; 1, tail limpness; 2,
impaired righting reflex; 3, hind limb weakness; 4, hind limb paralysis; 5, hind
limb paralysis with fore limb weakness; and 6, death).
Adoptive Transfer
Purified B cells (1 3 107 cells) from spleens of mice 28 days after MOG35-55
immunization were transferred intravenously into Stim1f/fStim2f/f Mb1cre/+
mice. B cells retrovirally transduced with GFP alone or IL-10-IRES-GFP were
sorted by a FACSAria cell sorter (BD Biosciences). A total of 1 3 106 GFP+
B cells were transferred intravenously into mMT mice 24 hr before EAE
induction.
Statistical Analysis
Statistical analyses were performed with the two-tailed unpaired Student’s
t test.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.immuni.2011.03.016.
ACKNOWLEDGMENTS
We thank E. Hobeika and M. Reth for mb-1 cre mice; D. Kitamura and
K. Rajewsky for mMT mice; T. Kitamura for pMY and pMX retroviral vectors;
and M. Lino for pMX-GFP-NFAT4 retroviral vector. We are thankful to
P.W. Kincade for critical reading of the manuscript. This work was supported
by Grant-in-Aids for Japan Science and Technology Agency and Core
Research for Evolutional Science and Technology (T.K.) and for the Ministry
of Education, Culture, Sports, Science and Technology, Japan (Y.B. and T.K.)
Received: October 19, 2010
Revised: February 2, 2011
Accepted: March 3, 2011
Published online: April 28, 2011
REFERENCES
Baba, Y., and Kurosaki, T. (2009). Physiological function and molecular basis
of STIM1-mediated calcium entry in immune cells. Immunol. Rev. 231,
174–188.
Baba, Y., Hayashi, K., Fujii, Y., Mizushima, A., Watarai, H., Wakamori, M.,
Numaga, T., Mori, Y., Iino, M., Hikida, M., and Kurosaki, T. (2006). Coupling
of STIM1 to store-operated Ca2+ entry through its constitutive and inducible
movement in the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 103,
16704–16709.
Baba, Y., Nishida, K., Fujii, Y., Hirano, T., Hikida, M., and Kurosaki, T. (2008).
Essential function for the calcium sensor STIM1 in mast cell activation and
anaphylactic responses. Nat. Immunol. 9, 81–88.
Bettelli, E., Das, M.P., Howard, E.D., Weiner, H.L., Sobel, R.A., and Kuchroo,
V.K. (1998). IL-10 is critical in the regulation of autoimmune encephalomyelitis
as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
J. Immunol. 161, 3299–3306.
Bishop, G.A. (2004). The multifaceted roles of TRAFs in the regulation of B-cell
function. Nat. Rev. Immunol. 4, 775–786.
Brandman, O., Liou, J., Park, W.S., and Meyer, T. (2007). STIM2 is a feedback
regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+
levels. Cell 131, 1327–1339.Braun, A., Gessner, J.E., Varga-Szabo, D., Syed, S.N., Konrad, S., Stegner, D.,
Vo¨gtle, T., Schmidt, R.E., and Nieswandt, B. (2009). STIM1 is essential for
Fcgamma receptor activation and autoimmune inflammation. Blood 113,
1097–1104.
Evans, J.G., Chavez-Rueda, K.A., Eddaoudi, A., Meyer-Bahlburg, A.,
Rawlings, D.J., Ehrenstein, M.R., and Mauri, C. (2007). Novel suppressive
function of transitional 2 B cells in experimental arthritis. J. Immunol. 178,
7868–7878.
Feske, S. (2007). Calcium signalling in lymphocyte activation and disease. Nat.
Rev. Immunol. 7, 690–702.
Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H., Tanasa, B.,
Hogan, P.G., Lewis, R.S., Daly, M., and Rao, A. (2006). A mutation in Orai1
causes immune deficiency by abrogating CRAC channel function. Nature
441, 179–185.
Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D., and Anderton, S.M.
(2002). B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3,
944–950.
Ghosh, S., Koralov, S.B., Stevanovic, I., Sundrud, M.S., Sasaki, Y., Rajewsky,
K., Rao, A., and Mu¨ller, M.R. (2010). Hyperactivation of nuclear factor of acti-
vated T cells 1 (NFAT1) in T cells attenuates severity of murine autoimmune
encephalomyelitis. Proc. Natl. Acad. Sci. USA 107, 15169–15174.
Goodridge, H.S., Simmons, R.M., and Underhill, D.M. (2007). Dectin-1 stimu-
lation by Candida albicans yeast or zymosan triggers NFAT activation in
macrophages and dendritic cells. J. Immunol. 178, 3107–3115.
Greenblatt, M.B., Aliprantis, A., Hu, B., and Glimcher, L.H. (2010). Calcineurin
regulates innate antifungal immunity in neutrophils. J. Exp. Med. 207, 923–931.
Grillot, D.A., Merino, R., Pena, J.C., Fanslow, W.C., Finkelman, F.D.,
Thompson, C.B., and Nunez, G. (1996). bcl-x exhibits regulated expression
during B cell development and activation and modulates lymphocyte survival
in transgenic mice. J. Exp. Med. 183, 381–391.
Hobeika, E., Thiemann, S., Storch, B., Jumaa, H., Nielsen, P.J., Pelanda, R.,
and Reth, M. (2006). Testing gene function early in the B cell lineage in mb1-
cre mice. Proc. Natl. Acad. Sci. USA 103, 13789–13794.
Kitamura, D., Roes, J., Ku¨hn, R., and Rajewsky, K. (1991). A B cell-deficient
mouse by targeted disruption of the membrane exon of the immunoglobulin
mu chain gene. Nature 350, 423–426.
Klein, U., and Dalla-Favera, R. (2008). Germinal centres: Role in B-cell physi-
ology and malignancy. Nat. Rev. Immunol. 8, 22–33.
Kuchroo, V.K., Martin, C.A., Greer, J.M., Ju, S.T., Sobel, R.A., and Dorf, M.E.
(1993). Cytokines and adhesion molecules contribute to the ability of myelin
proteolipid protein-specific T cell clones to mediate experimental allergic
encephalomyelitis. J. Immunol. 151, 4371–4382.
Lam, E.W., Glassford, J., Banerji, L., Thomas, N.S., Sicinski, P., and Klaus,
G.G. (2000). Cyclin D3 compensates for loss of cyclin D2 in mouse B-lympho-
cytes activated via the antigen receptor and CD40. J. Biol. Chem. 275,
3479–3484.
Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Caldero´n Go´mez, E.,
Sweenie, C.H., Hao, Y., Freitas, A.A., Steinhoff, U., Anderton, S.M., and
Fillatreau, S. (2008). TLR-activated B cells suppress T cell-mediated autoim-
munity. J. Immunol. 180, 4763–4773.
Lampropoulou, V., Calderon-Gomez, E., Roch, T., Neves, P., Shen, P.,
Stervbo, U., Boudinot, P., Anderton, S.M., and Fillatreau, S. (2010).
Suppressive functions of activated B cells in autoimmune diseases reveal
the dual roles of Toll-like receptors in immunity. Immunol. Rev. 233, 146–161.
Linington, C., Bradl, M., Lassmann, H., Brunner, C., and Vass, K. (1988).
Augmentation of demyelination in rat acute allergic encephalomyelitis by
circulating mouse monoclonal antibodies directed against a myelin/oligoden-
drocyte glycoprotein. Am. J. Pathol. 130, 443–454.
Liou, J., Kim, M.L., Heo, W.D., Jones, J.T., Myers, J.W., Ferrell, J.E., Jr., and
Meyer, T. (2005). STIM is a Ca2+ sensor essential for Ca2+-store-depletion-trig-
gered Ca2+ influx. Curr. Biol. 15, 1235–1241.
Lund, F.E., and Randall, T.D. (2010). Effector and regulatory B cells:
Modulators of CD4(+) T cell immunity. Nat. Rev. Immunol. 10, 236–247.Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc. 713
Immunity
Role of Ca2+ Influx in B Cell Regulatory FunctionLyons, J.A., San, M., Happ, M.P., and Cross, A.H. (1999). B cells are critical to
induction of experimental allergic encephalomyelitis by protein but not by
a short encephalitogenic peptide. Eur. J. Immunol. 29, 3432–3439.
Macian, F. (2005). NFAT proteins: Key regulators of T-cell development and
function. Nat. Rev. Immunol. 5, 472–484.
Matsushita, T., Yanaba, K., Bouaziz, J.D., Fujimoto, M., and Tedder, T.F.
(2008). Regulatory B cells inhibit EAE initiation in mice while other B cells
promote disease progression. J. Clin. Invest. 118, 3420–3430.
Matsushita, T., Horikawa, M., Iwata, Y., and Tedder, T.F. (2010). Regulatory B
cells (B10 cells) and regulatory T cells have independent roles in controlling
experimental autoimmune encephalomyelitis initiation and late-phase immu-
nopathogenesis. J. Immunol. 185, 2240–2252.
Mauri, C., and Ehrenstein, M.R. (2008). The ‘short’ history of regulatory B cells.
Trends Immunol. 29, 34–40.
Mauri, C., Gray, D., Mushtaq, N., and Londei, M. (2003). Prevention of arthritis
by interleukin 10-producing B cells. J. Exp. Med. 197, 489–501.
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R.S., and Bhan, A.K.
(2002). Chronic intestinal inflammatory condition generates IL-10-producing
regulatory B cell subset characterized by CD1d upregulation. Immunity 16,
219–230.
Neves, P., Lampropoulou, V., Calderon-Gomez, E., Roch, T., Stervbo, U.,
Shen, P., Ku¨hl, A.A., Loddenkemper, C., Haury, M., Nedospasov, S.A., et al.
(2010). Signaling via the MyD88 adaptor protein in B cells suppresses protec-
tive immunity during Salmonella typhimurium infection. Immunity 33, 777–790.
Oh-Hora, M., Yamashita, M., Hogan, P.G., Sharma, S., Lamperti, E., Chung,
W., Prakriya, M., Feske, S., and Rao, A. (2008). Dual functions for the endo-
plasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and
tolerance. Nat. Immunol. 9, 432–443.
Parekh, A.B., and Putney, J.W., Jr. (2005). Store-operated calcium channels.
Physiol. Rev. 85, 757–810.714 Immunity 34, 703–714, May 27, 2011 ª2011 Elsevier Inc.Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y.,
Hood, L., Zhu, Z., Tian, Q., and Dong, C. (2005). A distinct lineage of CD4
T cells regulates tissue inflammation by producing interleukin 17. Nat.
Immunol. 6, 1133–1141.
Picard, C., McCarl, C.A., Papolos, A., Khalil, S., Lu¨thy, K., Hivroz, C., LeDeist,
F., Rieux-Laucat, F., Rechavi, G., Rao, A., et al. (2009). STIM1 mutation asso-
ciated with a syndrome of immunodeficiency and autoimmunity. N. Engl.
J. Med. 360, 1971–1980.
Roos, J., DiGregorio, P.J., Yeromin, A.V., Ohlsen, K., Lioudyno, M., Zhang, S.,
Safrina, O., Kozak, J.A., Wagner, S.L., Cahalan, M.D., et al. (2005). STIM1, an
essential and conserved component of store-operated Ca2+ channel function.
J. Cell Biol. 169, 435–445.
Saraiva, M., and O’Garra, A. (2010). The regulation of IL-10 production by
immune cells. Nat. Rev. Immunol. 10, 170–181.
Varga-Szabo, D., Braun, A., Kleinschnitz, C., Bender, M., Pleines, I., Pham,M.,
Renne´, T., Stoll, G., and Nieswandt, B. (2008). The calcium sensor STIM1 is an
essential mediator of arterial thrombosis and ischemic brain infarction. J. Exp.
Med. 205, 1583–1591.
Wolf, S.D., Dittel, B.N., Hardardottir, F., and Janeway, C.A., Jr. (1996).
Experimental autoimmune encephalomyelitis induction in genetically B cell-
deficient mice. J. Exp. Med. 184, 2271–2278.
Yanaba, K., Bouaziz, J.D., Haas, K.M., Poe, J.C., Fujimoto, M., and Tedder,
T.F. (2008). A regulatory B cell subset with a unique CD1dhiCD5+ phenotype
controls T cell-dependent inflammatory responses. Immunity 28, 639–650.
Yanaba, K., Bouaziz, J.D., Matsushita, T., Tsubata, T., and Tedder, T.F. (2009).
The development and function of regulatory B cells expressing IL-10 (B10
cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182,
7459–7472.
